Updates in Headache Management
Headache treatment depends on accurate diagnoses, ruling out alternative etiologies, ordering appropriate studies, and addressing headache impact. Appropriate migraine preventive treatment is a combination of acute treatments that target the symptoms of the attack and preventive treatments that target the generation of attacks. In addition to the treatment options currently available, there is a multitude of promising new treatment modalities in development.
Stephen D. Silberstein, MD, Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Stephen D. Silberstein, MD, is a Professor of Neurology and the Director of the Jefferson Headache Center at Thomas Jefferson University. He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. In 2016, he was awarded a Lifetime Achievement Award by the American Headache Society. Dr Silberstein is an active member of the American Academy of Neurology and is Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He was the Chairman of the International Headache Society meeting in Philadelphia in 2009. He is Chairman of the headache research group of the World Federation of Neurology.
Dr. Silberstein received his medical degree from the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein served as a Pharmacology Research Associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health, and completed a neurology residency at the Hospital of the University of Pennsylvania.
Dr. Silberstein is the Senior Editor of the 8th edition of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNSDrugs, and a present or prior member of the Editorial Board of Headache; Cephalalgia; Acta Neurologica Scandinavica; Journal of Neurology, Neurosurgery & Psychiatry; and Topics in Pain Management. He is an ad hoc reviewer for many publications, including The New England Journal of Medicine; Brain, The Lancet, JAMA, Mayo Clinic Proceedings, Annals of Neurology, and Neurology.
Dr. Silberstein has more than 300 publications to his credit. He lectures extensively on the pathogenesis, neurobiology, diagnosis, and treatment of headache.
Updates in Headache Management
Wednesday, November 2
6:30-7:00pm Registration and Light Buffet Dinner
1. Learn about updated acute and preventive guidelines for migraine
2. Discuss new delivery systems and technologies of treatments
3. Discuss the emergence of neuromodulation as a new therapeutic approach to treatment of migraine.
Continuing Medical Education
This event is eligible for AMA PRA Category 2 Credit(s)™ where physicians may self claim one (l) AMA PRA Category 2 Credit for each 60-minute hour engaged in the learning activity. Individual physicians may claim AMA PRA Category 2 Credits for learning experiences that have improved the care they provide their patients and may be earned for activities physicians have undertaken on their own that should be beneficial to their practice.
Drexel University College of Medicine
Geary Auditorium A – New College Building, 1st Floor
SE Corner of 15th and Vine Streets, Philadelphia, PA
Parking is available across the street from the auditorium and is also available in the Gateway parking lot behind Magee Rehabilitation Hospital and costs $5.00 after 5:00pm